Schizophrenic patients taking part in integrated care program - CARE I
Study identifier:NIS-NDE-SER-2007/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Terminated/Withdrawn
Official Title
Evaluation of treatment outcomes in schizophrenic patients taking part in the integrated care program - a single-country, multi-centre non-interventional study
Medical condition
schizophrenia
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
20
Study type
Observational
Age
18 Years - 65 Years
Date
Study Start Date: 01 Jan 2008
Primary Completion Date: 01 Dec 2008
Study Completion Date: 01 Dec 2008
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
acromion GmbH, Frechen
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| All Schizophrenic outpatients who are treated with Seroquel IR and who are additionally intended to start with an integrated care program | - |
Contacts
Investigators
Principal Investigator
Sandra Liedtke
AstraZeneca
